IL-9–mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation

Jan‐Eric Turner(Universität Hamburg), Peter J. Morrison(Medical Research Council), Christoph Wilhelm(National Institutes of Health), Mark A. Wilson(Medical Research Council), Helena Ahlfors(Medical Research Council), Jean‐Christophe Renauld(Ludwig Cancer Research), Ulf Panzer(Universität Hamburg), Helena Helmby(University of London), Brigitta Stockinger(Medical Research Council)
The Journal of Experimental Medicine
November 18, 2013
Cited by 392Open Access
Full Text

Abstract

IL-9 fate reporter mice established type 2 innate lymphoid cells (ILC2s) as major producers of this cytokine in vivo. Here we focus on the role of IL-9 and ILC2s during the lung stage of infection with Nippostrongylus brasiliensis, which results in substantial tissue damage. IL-9 receptor (IL-9R)-deficient mice displayed reduced numbers of ILC2s in the lung after infection, resulting in impaired IL-5, IL-13, and amphiregulin levels, despite undiminished numbers of Th2 cells. As a consequence, the restoration of tissue integrity and lung function was strongly impaired in the absence of IL-9 signaling. ILC2s, in contrast to Th2 cells, expressed high levels of the IL-9R, and IL-9 signaling was crucial for the survival of activated ILC2s in vitro. Furthermore, ILC2s in the lungs of infected mice required the IL-9R to up-regulate the antiapoptotic protein BCL-3 in vivo. This highlights a unique role for IL-9 as an autocrine amplifier of ILC2 function, promoting tissue repair in the recovery phase after helminth-induced lung inflammation.


Related Papers

No related papers found

Powered by citation graph analysis